Colorectal cancer mortality rates predicted to increase globally

Jan 16, 2019

In the first effort to predict the future burden of colorectal cancer mortality globally, researchers note that colon and rectal cancer mortality rates are projected to decrease in most countries apart from some Latin American and Caribbean countries, but increases are predicted for several countries from Europe, North America and Oceania. The findings are published in the International Journal of Cancer. Despite these regional differences, the number of deaths is expected to rise in all countries for both colon and rectal cancer by 60.0 percent and 71.5 percent until 2035, respectively, due to population growth and aging. ...

Read More

AHA says penalties as well as incentives are needed to face down ‘persistent’ drug shortages

Jan 16, 2019

Persistent drug shortages have become dangerous and costly, the American Hospital Association says, forcing staff to use drugs with which they have less experience and that are sometimes more expensive. Responding to an FDA request for comment, the AHA, which represents 5,000 hospitals and 270,000 physicians, has crafted (PDF) a lengthy list of suggestions for addressing the problems that include both the carrot and the stick. It calls for some incentives to ensure drugmakers have contingency plans for producing essential drugs and to entice other drugmakers to make products that are often in need. But it also asks Congress to put penalties in place ...

Read More

SEKO Logistics invests in Ireland to serve customers thriving in one of Europe’s fastest-growing economies

Jan 16, 2019

SEKO Logistics’ core market investment strategy now includes the opening of its own operation in Ireland to serve multinational customers prospering in one of Europe’s fastest growing economies. According to the European Commission’s Interim Economic Forecast, Ireland is likely to have recorded the highest GDP growth in the EU in 2018, estimated at 5.6% versus 2.1% for the region overall. This follows the country’s strong momentum of 2017 when its 7.3% growth rate was three times higher than the Eurozone average. As SEKO Logistics has expanded its presence globally in recent years, it has strategically invested in new facilities in ...

Read More

Significant number of drugs will launch for the treatment of age-related macular degeneration by 2026, says GlobalData

Jan 16, 2019

The age-related macular degeneration (AMD) market has been dominated by big pharma companies and their pipeline candidates are ensuring a share of this lucrative market, in spite of patent expiries of their highly-priced products, according to GlobalData, a leading data and analytics company. Roche and Novartis’ Lucentis (ranibizumab) was the first anti-VEGF monoclonal antibody designed specifically for the treatment of the wet form of AMD. Currently these companies sponsor the highest number of clinical trials to reclaim their top position in the AMD space. Dr. Edit Kovalcsik, Managing Pharma Analyst at GlobalData, comments: “In recent years Regeneron and Bayer became ...

Read More

Development of drugs with novel MOAs marks a shift in glaucoma corporate strategy, says GlobalData

Jan 16, 2019

With no new classes of drugs having been developed for the treatment of glaucoma in the last twenty years, the focus of pharmaceutical companies has begun to shift towards the development of glaucoma drugs with novel mechanisms of action (MOAs), and this trend is expected to continue to 2026. The launch of 11 new therapies will drive growth in the glaucoma space, provide more options for patients, and stimulate further competition, says GlobalData, a leading data and analytics company. The glaucoma pipeline features 120 drugs across all stages of development, with more than two-thirds of the pipeline drugs being developed ...

Read More